Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2024-01-05 00:00:00 ET · period of report 2024-01-03 · accession 0000950170-24-002515 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-05 | 2024-01-03 | NTLA | Lebwohl David | EVP, Chief Medical Off | S - Sale | $29.46 | -5,843 | 54.4K | -10% | -$172.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-03 | S | D | 5,843 | $29.46 | 54,372 | D | — | — |